Oncology’s research Boom

Supported by

Inside Oncology's Research Boom

The long list of new treatments reflects the advent of cancer immunotherapy as well as continued progress in matching treatment to genetics. New drugs for lung, breast, skin and blood cancers have made gains over standard of care, while other additions have expanded options for patients.

  • Merck and Pfizer demonstrate how they tap sites for cancer trials
  • Impact of coronavirus on cancer research
  • Latest trends and challenges in cancer immunotherapy

Unlock the free Trendline by BioPharma Dive

This Material is  brought to you through is a library of technology content for Business Professionals and Decision Makers. To receive more free reports from your favorite companies. Please visit To know more about how The Medialytics might Process your personal data please read our privacy statement.